These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2283393)

  • 1. Use of solid-phase C1Q to remove soluble antigen/antibody complexes in an inhibition ELISA for streptococcal cell membrane antigens.
    Zelman ME; Lange CF
    J Immunoassay; 1990; 11(4):545-54. PubMed ID: 2283393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
    Garred P; Michaelsen TE; Aase A; Mollnes TE
    J Immunol; 1990 Jan; 144(1):198-203. PubMed ID: 2295791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
    Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
    Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
    Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
    J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of solid-phase Clq-ELISA for detecting circulating immune complexes in human diseases].
    Aleshkin VA; Nasonov EL; Eremeeva MV; Kobylianskiĭ AG
    Ter Arkh; 1989; 61(6):113-6. PubMed ID: 2477907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
    Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
    J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current situation and problems in the estimation of circulating immune complexes].
    Yoshida H
    Rinsho Byori; 1992 Jan; 40(1):28-33. PubMed ID: 1545522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
    Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
    Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct IgG1 and IgG3 subclass responses to two streptococcal protein antigens in man: analysis of antibodies to streptolysin O and M protein using standardized subclass-specific enzyme-linked immunosorbent assays.
    Falconer AE; Carson R; Johnstone R; Bird P; Kehoe M; Calvert JE
    Immunology; 1993 May; 79(1):89-94. PubMed ID: 8509146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological studies of post-streptococcal sequelae. Evidence for presence of streptococcal antigens in circulating immune complexes.
    Friedman J; van de Rijn I; Ohkuni H; Fischetti VA; Zabriskie JB
    J Clin Invest; 1984 Sep; 74(3):1027-34. PubMed ID: 6206091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
    Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
    J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on affinity constants of hapten-specific monoclonal antibodies using an antibody-immobilized ELISA.
    Chu KS; Jin S; Guo J; Jue M; Huang JJ
    Biotechnol Prog; 1995; 11(3):352-6. PubMed ID: 7619405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
    Soltis RD; Hasz DE
    J Clin Lab Immunol; 1982 Nov; 9(2):121-31. PubMed ID: 6984078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of circulating immune complexes in hematological diseases by Clq ELISA (a microplate method)].
    Hayashi S; Oshida M; Tsubakio T; Kurata Y
    Rinsho Byori; 1983 Jun; 31(6):621-4. PubMed ID: 6361331
    [No Abstract]   [Full Text] [Related]  

  • 18. R-ELISA: repeated use of antigen-coated plates for ELISA and its application for testing of antibodies to HIV and other pathogens.
    Baunoch DA; Das P; Browning ME; Hari V
    Biotechniques; 1992 Mar; 12(3):412-7. PubMed ID: 1571153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characterization of the antigen in circulating immune complexes and application to the detection of streptococcal antigens in human infectious endocarditis].
    Grangeot-Keros L; Lebrun L; Badur S; Sacquet E; Pillot J
    Ann Immunol (Paris); 1983; 134C(2):275-80. PubMed ID: 6408976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.